T2 Biosystems, Inc. announced the formation of its Scientific Advisory Board (SAB), comprising leading clinicians and researchers in the areas of infectious disease, laboratory medicine, and pharmacy. The newly formed SAB will provide insights regarding the company's clinical utilization, product pipeline, preclinical development, clinical research, clinical data generation, and strategic guidance to advance the Company's mission. The SAB is chaired by Aparna Ahuja, M.D., Chief Medical Officer of T2 Biosystems, the inaugural meeting was held during the first quarter of 2022, and the inaugural members include: Sean X. Zhang, M.D., Ph.D., D(ABMM) Dr. Zhang is an Associate Professor of Pathology at the Johns Hopkins University School of Medicine and the Medical Director of Medical Mycology Laboratory at the Johns Hopkins Hospital.

Dr. Zhang's research focuses on developing rapid and nonculture-based tools for fungal diagnostics.